aBstRact This paper presents a patient of primary submandibular gland adenocarcinoma later presenting with renal metastasis. Renal cancers are known for their predisposition to unusual metastasis to other organs. On the contrary, renal metastasis from salivary gland tumours is extremely rare with no adenocarcinoma reported from the submandibular gland to date. Hence the significance of adequate history taking, immunohistochemical identification of pathology and multidisciplinary approach in the management of such rare clinical presentation is discussed here. The metastatic disease should always be a differential when evaluating cancer patients regardless of the interval since previous disease or rarity of occurrence.
Renal metastasis from salivary gland tumours is extremely rare with no adenocarcinoma reported from the submandibular gland to date. 1 On the contrary, renal cancers are known for their predisposition to unusual metastasis. We present a case of primary submandibular gland adenocarcinoma that resulted in renal metastasis.
case RePoRt
A 59-year-old man presented to urology with a self-resolved painless visible hematuria with clots. He was a carpenter by profession, non-smoker, and had no family history of urological malignancies. His only medical history was excision of a 19-mm painless right submandibular gland lesion two-years previous for presumed pleomorphic adenoma on the basis of fine-needle aspiration. Histology reported incomplete excision of poorly differentiated adenocarcinoma with neuroendocrine activity and marked perineural spread. Therefore, wide local excision and ipsilateral neck dissection were performed with several positive margins and 2 out of 6 lymph nodes showing metastasis. No distant metastasis noted. Postoperative adjuvant radiotherapy was given.
Following standard hematuria investigations, a new non-palpable 56-mm left-renal mass infi ltrating the renal pelvis and lower pole pelvicalyceal system was reported on computed tomography (CT) urogram (Figure 1 and 2 ) which was biopsied. CT fi ndings were similar to renal cell carcinoma with increased enhancement in the contrast phase. Interestingly histology revealed a poorly diff erentiated carcinoma with morphological and immunohistochemical similarity to the previous submandibular gland cancer. Histology slides were also sent to another tertiary centre for specialist review and validation. After extensive immunohistochemical examination, the fi nal consensus from urology and ENT multidisciplinary team meetings was the diagnosis of metastatic adenocarcinoma DOI: 10.22374/jeleu.v2i3.30 of submandibular gland with secondary involvement of the kidney.
Restaging CT scan detected multiple new small irregular speculate nodules in the right lung highly suggestive of metastasis. Due to this evidence of further non-renal metastasis palliative chemotherapy (epirubicin, cisplatin and capecitabine) was commenced. The patient had no further hematuria episodes. Since he is asymptomatic in follow up in relation to renal metastases, no further treatment required.
Pathology and discussion
Literature review suggests renal cancer metastases to salivary glands are extremely rare and histologically either oncocytic or clear cell variants. [2] [3] [4] [5] The reverse metastases are more improbable with 2 reported case of adenoid cystic carcinoma of parotid gland resulting in late renal metastasis. 1, 6 Although renal metastasis from submandibular gland appears not to have been reported, renal metastasis from other salivary gland has, although still very rare. 7, 8 These were treated surgically with very limited benefits of radiotherapy, chemotherapy, and hormonal therapy.
In our case, the salivary gland tumour showed nests, tubules, and trabeculae of monotonous rounded cells with perineural invasion. Ki67 index was less than 30%. A renal biopsy also showed infiltrative tumour composed of nests and tubules of similar monotonous cells with low mitotic activity. Kidney tumour cells are negative with CD10, p63, CK20, PSA, CD99, TTF1, GATA3, S100, calponin, caldesmon, synaptophysin, and chromogranin; focally positive for CK5/6, SMA, EMA, and diffusely and strongly positive with CK7, CK19, Vimentin, CD56 and WT1. The submandibular tumour was negative for p63, CK20, PSA, TTF1, GATA3, calponin, caldesmon, synaptophysin, and chromogranin and positive with CK5/6, SMA, EMA, CK7, CK19, 34betaE12, Vimentin, CD56 and WT1. Hence, morphology and immunohistochemistry support renal metastasis from submandibular gland cancer. Results were summarized in Table 1 and Figure 3 . The rarity of this occurrence resulted in extensive immunohistochemical examinations and specialist reviews to confirm the final diagnosis.
conclusion
This case report emphasizes the rare renal tumour, the significance of histological identification of primary cancer and metastasis as they form the basis of therapeutic decisions. The metastatic disease should always be a differential when evaluating cancer patients regardless of the interval since previous disease or rarity of occurrence. These tumours are difficult to be differentiated from standard renal cell carcinoma (RCC) purely by standard triple phase contrast CT. The learning points from this case report are careful history taking and the role of renal biopsy for these types of patients and careful liaison with histopathologists to differentiate it from RCC. CD10  -P63  --CK20  --PSA  --CD99  -TTF1  --GATA3  --S100  -CALPONIN  --CALDESMON  --SYNAPTOPHYSIN  --CHROMOGRANIN  --CK5/6  +  +  CK7  +  +  CK19  +  +  CD56  +  +  WT1  +  +  SMA  +  +  EMA  +  +  VIMENTIN  +  + 
